A Patient-Derived Xenograft Model of Glioblastoma

Summary: Glioblastoma (GBM) remains the most common malignant primary brain tumor in adults with a median survival of less than ~15 months. Further understanding and therapeutic development rely on the use of clinically relevant models of GBM. Here, we present our patient-derived in vitro and in viv...

Full description

Bibliographic Details
Main Authors: Chirayu R. Chokshi, Neil Savage, Chitra Venugopal, Sheila K. Singh
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166720301660
id doaj-f04cc8d3234044c9bf5bf5b44a88dbfc
record_format Article
spelling doaj-f04cc8d3234044c9bf5bf5b44a88dbfc2020-12-21T04:49:02ZengElsevierSTAR Protocols2666-16672020-12-0113100179A Patient-Derived Xenograft Model of GlioblastomaChirayu R. Chokshi0Neil Savage1Chitra Venugopal2Sheila K. Singh3Department of Biochemistry, McMaster University, Hamilton, ON L8S 4L8, CanadaDepartment of Biochemistry, McMaster University, Hamilton, ON L8S 4L8, CanadaDepartment of Surgery, McMaster University, Hamilton, ON L8S 4L8, CanadaDepartment of Biochemistry, McMaster University, Hamilton, ON L8S 4L8, Canada; Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada; Corresponding authorSummary: Glioblastoma (GBM) remains the most common malignant primary brain tumor in adults with a median survival of less than ~15 months. Further understanding and therapeutic development rely on the use of clinically relevant models of GBM. Here, we present our patient-derived in vitro and in vivo models that enrich for GBM stem cells (GSCs), a subpopulation of tumor cells with stem cell-like properties that recapitulate the cellular heterogeneity of its parental tumor and resist conventional therapy and seed disease relapse.For complete details on the use and execution of this protocol, please refer to Vora et al. (2020).http://www.sciencedirect.com/science/article/pii/S2666166720301660Cell cultureCell isolationCancerModel Organisms
collection DOAJ
language English
format Article
sources DOAJ
author Chirayu R. Chokshi
Neil Savage
Chitra Venugopal
Sheila K. Singh
spellingShingle Chirayu R. Chokshi
Neil Savage
Chitra Venugopal
Sheila K. Singh
A Patient-Derived Xenograft Model of Glioblastoma
STAR Protocols
Cell culture
Cell isolation
Cancer
Model Organisms
author_facet Chirayu R. Chokshi
Neil Savage
Chitra Venugopal
Sheila K. Singh
author_sort Chirayu R. Chokshi
title A Patient-Derived Xenograft Model of Glioblastoma
title_short A Patient-Derived Xenograft Model of Glioblastoma
title_full A Patient-Derived Xenograft Model of Glioblastoma
title_fullStr A Patient-Derived Xenograft Model of Glioblastoma
title_full_unstemmed A Patient-Derived Xenograft Model of Glioblastoma
title_sort patient-derived xenograft model of glioblastoma
publisher Elsevier
series STAR Protocols
issn 2666-1667
publishDate 2020-12-01
description Summary: Glioblastoma (GBM) remains the most common malignant primary brain tumor in adults with a median survival of less than ~15 months. Further understanding and therapeutic development rely on the use of clinically relevant models of GBM. Here, we present our patient-derived in vitro and in vivo models that enrich for GBM stem cells (GSCs), a subpopulation of tumor cells with stem cell-like properties that recapitulate the cellular heterogeneity of its parental tumor and resist conventional therapy and seed disease relapse.For complete details on the use and execution of this protocol, please refer to Vora et al. (2020).
topic Cell culture
Cell isolation
Cancer
Model Organisms
url http://www.sciencedirect.com/science/article/pii/S2666166720301660
work_keys_str_mv AT chirayurchokshi apatientderivedxenograftmodelofglioblastoma
AT neilsavage apatientderivedxenograftmodelofglioblastoma
AT chitravenugopal apatientderivedxenograftmodelofglioblastoma
AT sheilaksingh apatientderivedxenograftmodelofglioblastoma
AT chirayurchokshi patientderivedxenograftmodelofglioblastoma
AT neilsavage patientderivedxenograftmodelofglioblastoma
AT chitravenugopal patientderivedxenograftmodelofglioblastoma
AT sheilaksingh patientderivedxenograftmodelofglioblastoma
_version_ 1724375538197331968